REDHILL BIOPHARMA LTD. Noncurrent Restricted Cash And Cash Equivalents
REDHILL BIOPHARMA LTD. (RDHL) had Noncurrent Restricted Cash And Cash Equivalents of $148.00 thousand as of 2024-12-31, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:NoncurrentRestrictedCashAndCashEquivalents · last filed 2025-09-05
- 2024-12-31: Noncurrent Restricted Cash And Cash Equivalents $148.00K.
- 2024-06-30: Noncurrent Restricted Cash And Cash Equivalents $143.00K.
- 2023-12-31: Noncurrent Restricted Cash And Cash Equivalents $147.00K.
- 2023-06-30: Noncurrent Restricted Cash And Cash Equivalents $144.00K.
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | $148.00K 6-K · filed 2025-09-05 |
| 2024-06-30 | $143.00K 6-K · filed 2024-08-29 |
| 2023-12-31 | $147.00K 20-F · filed 2025-04-10 |
| 2023-06-30 | $144.00K 6-K · filed 2023-08-17 |
| 2022-12-31 | $150.00K 20-F · filed 2024-04-08 |
| 2022-06-30 | $150.00K 6-K · filed 2022-11-07 |
| 2021-12-31 | $16.17M 20-F · filed 2023-04-28 |
| 2021-06-30 | $16.16M 6-K · filed 2021-08-26 |
| 2020-12-31 | $16.16M 20-F · filed 2022-03-17 |
| 2020-06-30 | $20.15M 6-K · filed 2020-08-13 |
| 2019-12-31 | $152.00K 20-F · filed 2021-03-18 |